LEHI, Utah and LOUISVILLE, Ky., March 4, 2025 /PRNewswire/ -- Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, today announced the results of a comprehensive Qualtrics market survey identifying the top revenue cycle management (RCM) trends of 2025. The study surveyed 600 healthcare RCM, finance, and technology leaders from provider organizations of all types and sizes. The findings show that decision-makers are actively prioritizing AI and advanced automation to address critical challenges, with a focus on automation in patient access and claim management.
Healthcare leaders face mounting pressure from rising administrative costs, increasing claim denials, payer conflicts, and cybersecurity threats. The research highlights a strong shift toward strategic software investments that accelerate cash flow, adapt to evolving payer policies, and optimize performance.
The top six trends for healthcare leaders in 2025 include:
"Healthcare leaders are clear on their investment priorities for 2025: AI and advanced automation are critical to improving efficiency, accuracy, and security," said Matt Hawkins, Chief Executive Officer of Waystar. "Waystar is focused on delivering AI-powered software that maximizes return on investment for providers and simplifies healthcare payments in an increasingly complex landscape."
Waystar will discuss these findings during the 2025 HIMSS Global Healthcare Conference & Exhibition including at a panel on Tuesday, March 4 at 10:15 a.m. PT at The Venetian, Level 3, San Polo 3504. Attendees can also visit Waystar at Booth 4643 throughout the conference.
The full report is available at Waystar.com.
About Waystar
Waystar's mission-critical software is purpose-built to simplify healthcare payments so providers can prioritize patient care and optimize their financial performance. Waystar serves approximately 30,000 clients, representing over 1 million distinct providers, including 16 of 20 institutions on the U.S. News Best Hospitals list. Waystar's enterprise-grade platform annually processes over 6 billion healthcare payment transactions, including over $1.8 trillion in annual gross claims and spanning approximately 50% of U.S. patients. Waystar strives to transform healthcare payments so providers can focus on what matters most: their patients and communities. Discover the way forward at waystar.com.
Media Contact
Kristin Lee
This email address is being protected from spambots. You need JavaScript enabled to view it.
Investor Contact
Sandy Draper
This email address is being protected from spambots. You need JavaScript enabled to view it.
502-238-9511
Last Trade: | US$36.45 |
Daily Change: | -0.26 -0.71 |
Daily Volume: | 1,088,216 |
Market Cap: | US$6.270B |
February 24, 2025 February 18, 2025 February 18, 2025 January 13, 2025 January 06, 2025 |
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MORETerns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MOREEnd of content
No more pages to load